RESUMEN
BACKGROUND: Daclatasvir (DCV) combinated with Sofosbuvir (SOF) has shown good efficacy and safety profile for HCV patients. The aim was to evaluate the cost-effectiveness of DCV/SOF regimen versus HCV alternative treatments for patients who failed to achieve the SVR12 after a first DAA treatment from Italian perspective (PITER cohort). METHODS: A Markov model of HCV chronically infected patients was used to develop two scenarios: 1) DCV+ SOF versus Ledipasvir (LDV)+ SOF in Genotype (Gt)1 and Gt4; 2) DCV+ SOF versus no retreatment option in Gt1, Gt3, and Gt4. The percentage of patients who failed the first line with SOF/Simeprevir/Ribavirin (RBV) or SOF/RBV and were retreated or not according to evidences from PITER cohort, were used to populate the model. HCV resources consumption and SVR rates were quantified using PITER data. Transition probabilities and utility rates were derived from the literature. The outcomes were expressed in terms of Quality adjusted life years (QALYs). Probabilistic sensitivity analysis (PSA) was performed considering a cost-effectiveness threshold of 30,000/QALY. RESULTS: In the base-case analysis, DCV+ SOF represents a cost-effectiveness therapy with ICERs lower than the threshold. The PSA showed robust results, ICERs remain below the threshold in 94% and 99% simulations in Scenario 1 and 2, respectively.
Asunto(s)
Antivirales/administración & dosificación , Hepatitis C Crónica/tratamiento farmacológico , Imidazoles/administración & dosificación , Sofosbuvir/administración & dosificación , Antivirales/economía , Bencimidazoles/administración & dosificación , Bencimidazoles/economía , Carbamatos , Estudios de Cohortes , Análisis Costo-Beneficio , Quimioterapia Combinada , Fluorenos/administración & dosificación , Fluorenos/economía , Genotipo , Hepatitis C Crónica/economía , Humanos , Imidazoles/economía , Italia , Cadenas de Markov , Pirrolidinas , Años de Vida Ajustados por Calidad de Vida , Ribavirina/administración & dosificación , Simeprevir/administración & dosificación , Sofosbuvir/economía , Uridina Monofosfato/administración & dosificación , Uridina Monofosfato/análogos & derivados , Uridina Monofosfato/economía , Valina/análogos & derivadosRESUMEN
PURPOSE: The prevalence of anti-hepatitis E virus (HEV) and anti-hepatitis A virus (HAV), as well as the possible links with socio-demographic and other viral risks factors, were evaluated in an inmates population. METHODS: The study population consisted of 973 consecutively recruited inmates of eight Italian prisons. RESULTS: The anti-HEV prevalence was 11.6 % (113/973). It increased significantly by age (χ(2) for linear trend: p = 0.001) and was significantly higher among non-Italian compared to Italian inmates (15.3 vs. 10.7 %, respectively). Age >40 years [odds ratio (OR) 2.1; 95 % confidence interval (CI) 1.4-3.1], non-Italian citizenship (OR 1.8; 95 % CI 1.1-2.9) and anti-HIV seropositivity (OR 2.2; 95 % CI 1.2-4.2) were the only factors independently associated to anti-HEV positivity by logistic regression analysis. The overall anti-HAV prevalence was 86.4 %, and was significantly higher in non-Italian compared to Italian prisoners (92.6 vs. 84.9 %, respectively; p = 0.02). Age older than 40 years (OR 3.6; 95 % CI 2.2-5.9), <5 years formal education (OR 2.1; 95 % CI 1.3-3.2) and non-Italian nationality (OR 2.7; 95 % CI 1.5-4.8) were factors independently associated to anti-HAV positivity by the logistic regression analysis. CONCLUSIONS: Compared to the general population, significantly higher anti-HEV and anti-HAV prevalences were observed in an inmates population in Italy. Old age and non-Italian nationality were factors independently related to both HEV and HAV exposures. This data suggest the important role of low socio-economic factors in the transmission of both infections in high-risk populations. The possible epidemiological and/or pathogenetic links between HEV and HIV exposures need to be studied further.
Asunto(s)
Virus de la Hepatitis A/inmunología , Hepatitis A/epidemiología , Virus de la Hepatitis E/inmunología , Hepatitis E/epidemiología , Vigilancia de la Población , Adolescente , Adulto , Factores de Edad , Anciano , Femenino , Anticuerpos Antihepatitis/sangre , Anticuerpos Antihepatitis/inmunología , Humanos , Italia/epidemiología , Masculino , Persona de Mediana Edad , Factores de Riesgo , Estudios Seroepidemiológicos , Adulto JovenRESUMEN
BACKGROUND AND AIM: Acute hepatitis B course may be significantly modified by underlying chronic hepatitis C. The aim of this study was to compare clinical and virological characteristics of acute hepatitis B in patients with or without chronic hepatitis C virus (HCV) infection. MATERIALS AND METHODS: Twenty-seven patients with symptomatic acute hepatitis B were enrolled: 14 with underlying chronic HCV (Group A) and 13, matched by age and gender, with single hepatitis B (Group B). All patients were followed-up until HBsAg negativization. RESULTS: Group A patients were HCV-RNA-negative on hospital admission and all but one remained negative during follow-up. HBeAg tested positive in 92.9% and 84.6% of Groups A and B patients, respectively. ALT, bilirubin, prothrombin time values and HBsAg titer were similar in both groups. Nevertheless, lower mean HBV-DNA levels (p=0.03), a shorter duration of HBsAg positivity (p<0.01) and of symptoms before ALT peak (p=0.014), and significantly lower peak ALT values (p=0.03) were observed in Group A compared to Group B patients. CONCLUSIONS: Acute HBV infection suppressed HCV replication. Conversely, the underlying HCV infection exerted a modulatory effect on HBV replication which influenced the course, though not the outcome, of the acute disease. Although acute hepatitis B showed a mild clinical course in both groups of patients, HBV vaccination should be suggested to risk subjects.
Asunto(s)
Anticuerpos contra la Hepatitis B/inmunología , Hepatitis B/inmunología , Anticuerpos contra la Hepatitis C/inmunología , Hepatitis C Crónica/inmunología , ARN Viral/análisis , Sobreinfección/virología , Replicación Viral , Enfermedad Aguda , ADN Viral/inmunología , Femenino , Hepacivirus/genética , Hepacivirus/inmunología , Hepatitis B/complicaciones , Hepatitis B/epidemiología , Antígenos de Superficie de la Hepatitis B/sangre , Anticuerpos contra la Hepatitis C/sangre , Hepatitis C Crónica/complicaciones , Hepatitis C Crónica/epidemiología , Humanos , Masculino , ARN Viral/inmunología , Estudios Seroepidemiológicos , Sobreinfección/epidemiologíaRESUMEN
BACKGROUND: Albania is a Mediterranean, South-East European developing country where epidemiological data on infectious diseases are scarce. In this study, the seroprevalence of Helicobacter pylori infection in 1,088 Albanian healthy volunteers (472 females followed-up to a prenatal clinic, 173 recruits, 443 health care workers) was evaluated. MATERIALS AND METHODS: Sera were tested for immunoglobulin-G (IgG) antibodies against H. pylori using a quantitative enzyme immunosorbent assay. RESULTS: The overall H. pylori seroprevalence was 70.7%. The H. pylori seroprevalence increased by age, from 60.4% in individuals younger than 20 years to 81% among those > or = 50 years of age with a significant trend of increase by age. The overall seroprevalence was 73.9% for females and 59.5% for males. In addition the seroprevalence was 55.3% for people living in rural areas and 72.3% for people living in urban areas. No significant differences were found according to level of education except for individuals with elementary level of education. Nurses and hospital auxiliaries have significantly higher H. pylori seroprevalence when compared to other health care workers (physicians and office workers). When each variable (age, gender, area of residence, occupation, and education level) was adjusted for the confounding effect of the other variables by stepwise logistic analysis, we observed that age greater than 40 years and female gender remain the only variables independently associated with the presence of H. pylori IgG antibodies. CONCLUSIONS: H. pylori is highly prevalent among the Albanian population. Improving living conditions, education in hygiene, and the supply of running water are measures to prevent the transmission of H. pylori infection and other infections spread by the fecal-oral route in Albania.
Asunto(s)
Anticuerpos Antibacterianos/sangre , Infecciones por Helicobacter/diagnóstico , Infecciones por Helicobacter/epidemiología , Helicobacter pylori/inmunología , Helicobacter pylori/aislamiento & purificación , Voluntarios , Adulto , Distribución por Edad , Albania/epidemiología , Demografía , Femenino , Salud , Infecciones por Helicobacter/inmunología , Humanos , Inmunoglobulina G/sangre , Masculino , Persona de Mediana Edad , Embarazo , Estudios Seroepidemiológicos , Factores SexualesRESUMEN
BACKGROUND: Health care workers (HCW) have an elevated risk of acquiring and transmitting parenteral infections. The aim of this study was to evaluate the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) markers with the final goal to encourage HBV vaccination of the non-immune Albanian HCW. METHODS: Among 480 HCW enrolled, 92 were physicians, 246 were nurses/techniques, 120 were auxiliary workers and 22 were office workers. RESULTS: The HBsAg, anti-HBc and anti-HCV prevalence were 8.1%, 70% and 0.6%, respectively. The highest (11.4%) HBsAg prevalence was observed in the youngest age group (20-30 years of age). High HBsAg prevalence (7.2-7.5%) was detected also in age groups above 30 years. The highest HBsAg prevalence (12.6%) was found in the auxiliaries. The anti-HBc prevalence increased significantly with age from 59% in HCWs younger than 39 years to 87% among those older than 50 years. After adjustments for different job categories, age older than 40 years remained independently associated with anti-HBc positivity (OR = 2.9; 95% CI 1.9-4.6) and inversely associated with the lack of HBV immunity or infection markers (OR = 0.4; 95% CI 0.2-0.7). Of 142 HBsAg negative and/or anti-HBc Ab negative sera, 28 (20%) tested positive for anti-HBs. The 114 remaining individuals with no HBV infection or immunity markers were vaccinated against HBV infection. CONCLUSIONS: A high HBV infection rate and low HBV vaccination coverage were found in Albanian HCW. Albania is a Mediterranean country still highly endemic for HBV infection and new strategies to promote HBV vaccination are to be adopted.
Asunto(s)
Personal de Salud , Hepatitis B/epidemiología , Adulto , Albania/epidemiología , Femenino , Hepatitis B/prevención & control , Anticuerpos contra la Hepatitis B/sangre , Antígenos de Superficie de la Hepatitis B/sangre , Vacunas contra Hepatitis B/inmunología , Humanos , Masculino , Persona de Mediana Edad , VacunaciónRESUMEN
AIM: To evaluate the risk of recurrence of hepatocellular cancer (HCC) after liver transplantation (LT). METHODS: The clinical records of 104 patients with HCC in the explanted liver were examined. RESULTS: HCC recurrence occurred in 12 patients. Recurrence was observed in all patients with a single nodule greater than 5 cm. Among the 5 patients with more than 3 tumours with a maximum diameter of 4.5 cm, no recurrence occurred. The survival rates were 81% and 64% at 1 and 5 years, respectively; the recurrence-free survival at 1 and 5 years was, respectively, 93% and 82%. Pre-LT alpha-fetoprotein (AFP) increased at a greater magnitude in patients who experienced recurrence, compared to those who did not. Tumour diameter, differentiation, satellitosis, AFP and the magnitude of AFP increase were predictive of recurrence. The 1- and 5-year recurrence-free survival for the 68 patients who had a single nodule up to 5 cm, or up to 3 nodules all less than 4.5 cm and with a maximum cumulative diameter of 8 cm, or more than 3 nodules all less than 2.5 cm, were 95% and 92%, respectively. For the 13 patients not meeting these criteria, the 1- and 5-year recurrence-free survival was, respectively, 75% and 54% (log Rank test p=0.019). CONCLUSIONS: Patients with more than 3 small HCC nodules before LT could still have a good outcome without recurrence. A rapid increase in AFP could be useful in identifying patients with a greater risk of post-LT HCC recurrence.
Asunto(s)
Carcinoma Hepatocelular/epidemiología , Neoplasias Hepáticas/epidemiología , Trasplante de Hígado , Recurrencia Local de Neoplasia/epidemiología , Adulto , Anciano , Biomarcadores de Tumor/sangre , Carcinoma Hepatocelular/patología , Carcinoma Hepatocelular/cirugía , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Neoplasias Hepáticas/patología , Neoplasias Hepáticas/cirugía , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/sangre , Recurrencia Local de Neoplasia/patología , Estadificación de Neoplasias , Pronóstico , Modelos de Riesgos Proporcionales , Estudios Retrospectivos , Factores de Riesgo , Tasa de Supervivencia , Reino Unido/epidemiología , alfa-Fetoproteínas/metabolismoRESUMEN
Reported here are details of a simultaneous outbreak of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections that occurred in a hemodialysis centre in northern Italy, with three patients seroconverting for HBsAg and four patients seroconverting for HCV antibodies. Phylogenetic analysis of the E2 region of the isolates from HCV-seroconverted patients showed the sequences were grouped in the same distinct branch as in a chronically HCV-infected patient, suggesting that the chronically infected patient was the index case. For the patients with HBV infection, phylogenetic analysis showed strong clustering among the sequences of the three patients who seroconverted to HBsAg and no relatedness between them and the sequences of patients chronically infected with HBV. For one of the patients who seroconverted to HBsAg, the last test with negative results for HBV markers had been performed 18 months prior to HBsAg seroconversion. This patient may have been previously infected with HBV and is presumed to be the source of the outbreak. This report emphasizes the importance of using universal precaution measures and HBV vaccination to prevent the transmission of viral hepatitis among chronic hemodialysis patients.
Asunto(s)
Brotes de Enfermedades , Hepatitis B/epidemiología , Hepatitis C/epidemiología , Diálisis Renal , Hepacivirus/clasificación , Hepatitis B/complicaciones , Hepatitis B/prevención & control , Virus de la Hepatitis B/clasificación , Hepatitis C/complicaciones , Hepatitis C/prevención & control , Humanos , Inmunización , Italia/epidemiología , Grupo de Atención al Paciente , Vacunas contra Hepatitis Viral/administración & dosificaciónRESUMEN
A case-control study involving 109 in-patients with chronic liver disease and 190 in-patients with no apparent liver disease was conducted to evaluate the seroprevalence of anti-HEV antibodies and the possible association with chronic liver disease. Among cases, the anti-HEV prevalence was 36.6% which increased significantly by age; among controls, the prevalence was 12.1% (P<0.05) and was similar among age groups <60 years. Among cases, aged >50 years (OR 4.0, 95% CI 1.4-11) and the presence of end stage liver disease (ESLD) (OR 4.3, 95% CI 1.4-12.8) were associated independently with anti-HEV positivity. The mean optical density, determined by anti-HEV immunoenzymatic test, was significantly higher among patients with ESLD, compared to the other patients. These results indicate that there is a high seroprevalence of anti-HEV in patients with chronic liver disease and a possible association between HEV infection and/or anti-HEV production and advanced stage chronic liver disease.
Asunto(s)
Hepatitis E/complicaciones , Hepatopatías/virología , Factores de Edad , Anciano , Albania/epidemiología , Anticuerpos Antivirales/análisis , Estudios de Casos y Controles , Enfermedad Crónica , Femenino , Hepatitis E/epidemiología , Hepatitis E/virología , Virus de la Hepatitis E , Humanos , Hepatopatías/epidemiología , Masculino , Persona de Mediana Edad , Estudios SeroepidemiológicosRESUMEN
Albania is a Mediterranean country, still with a high endemicity level of hepatitis B virus (HBV) infection. The chronic hepatitis B profile was characterized in this geographical area and used as a model to investigate the impact of endemicity level on the prevalence of the two major forms of chronic hepatitis B (HBeAg-positive and HBeAg-negative chronic hepatitis B). A cross-sectional study was conducted among 62 chronic hepatitis B patients consecutively admitted to the most important tertiary health care center for the diagnosis and treatment of liver disease in Albania. HBV-DNA was measured with an in-house PCR with a sensitivity of 10(4) copies/ml which uses primers encompassing the pre-core/core region. PCR products were subjected to sequencing and oligohybridization assay. Of the 62 patients, 75.8% had HBeAg-negative chronic hepatitis B. Genotype D was found in all 39 patients with detectable HBV viremia, for whom the heterogeneity of the region modulating HBeAg expression was assessed. Basic core promoter (BCP) mutations (1762/1764) were observed more often in anti-HBe-positive and older patients. In more than 90% of the HBeAg-negative chronic hepatitis B patients with detectable viremia, HBV that carries the G to A pre-core mutation at nucleotide 1896 was found. Patients with HBeAg-positive chronic hepatitis B were younger than HBeAg-negative chronic hepatitis B patients, and for symptomatic and asymptomatic liver-disease patients, the age of peak prevalence was at least 10 years lower for HBeAg-positive chronic hepatitis B patients. In conclusion, the virological and clinical pattern of chronic hepatitis B in Albania is similar to that observed in other Mediterranean countries; it seems to be independent of the HBV endemicity level.
Asunto(s)
Virus de la Hepatitis B/genética , Hepatitis B Crónica/epidemiología , Hepatitis B Crónica/virología , Adulto , Factores de Edad , Anciano , Albania/epidemiología , ADN Viral/sangre , ADN Viral/química , Variación Genética , Genotipo , Antígenos e de la Hepatitis B/sangre , Virus de la Hepatitis B/clasificación , Virus de la Hepatitis B/aislamiento & purificación , Humanos , Hígado/patología , Persona de Mediana Edad , Epidemiología Molecular , Hibridación de Ácido Nucleico , Mutación Puntual/genética , Regiones Promotoras Genéticas/genética , Análisis de Secuencia de ADN , ViremiaRESUMEN
There are limited data on the use of lamivudine for patients with severe forms of acute hepatitis B. We report our experience with the use of lamivudine in six patients with acute HBV infection. Lamivudine was justified by disease severity for four patients and by concerns about risk of chronicity for two patients. The diagnoses of the treated patients were: fulminant liver failure (two patients), severe acute hepatitis B, protracted acute hepatitis B, and new HBV infection in the renal dialysis setting (two patients, one with severe liver injury). Serum HBV DNA titres ranged from 10(5) to 10(7) copies/mL prior to commencement of lamivudine. Lamivudine treatment was associated with a decline in serum HBV DNA and serum transaminases in all patients. All but one patient survived. A 58-year-old man with fulminant hepatitis and multiple organ failure died despite antiviral treatment. When possible, HBeAg and HBsAg seroconversion was documented during follow-up. In the absence of a randomized, prospective study of lamivudine in patients with severe acute hepatitis B, our data encourage the use of this safe and well tolerated drug.
Asunto(s)
Hepatitis B/tratamiento farmacológico , Lamivudine/uso terapéutico , Inhibidores de la Transcriptasa Inversa/uso terapéutico , Enfermedad Aguda , Adulto , Anciano , ADN Viral/sangre , Femenino , Hepatitis B/fisiopatología , Hepatitis B/virología , Humanos , Fallo Hepático/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Diálisis Renal , Índice de Severidad de la Enfermedad , Resultado del TratamientoRESUMEN
The presence of SENV and TTV infections among 50 patients who had undergone liver transplantation was evaluated. UTR amplification showed that 46 (92%) sera were positive. ORF-1 amplification showed that 25 (50%) patients were positive for either SENV (51.3%), TTV (10.8%), or both (37.8%) all confirmed by sequencing and phylogenetic analysis. SENV-D and SENV-H were the most prevalent viruses. The phylogenetic analysis of isolates showed that whereas SENV-D and SENV-G viruses showed sequence stability and strain persistence, SENV-H had cleared or mutated. Biological differences seem to exist among different genotypes in terms of viral replication and their persistence.
Asunto(s)
Infecciones por Circoviridae/virología , Circoviridae/genética , Circoviridae/aislamiento & purificación , Trasplante de Hígado , Torque teno virus/genética , Regiones no Traducidas 5' , Circoviridae/clasificación , ADN Viral/sangre , ADN Viral/química , Femenino , Genes Virales , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Sistemas de Lectura Abierta , Filogenia , Reacción en Cadena de la Polimerasa , Análisis de Secuencia de ADN , Torque teno virus/clasificación , Torque teno virus/aislamiento & purificaciónRESUMEN
Bacillus cereus is a food-borne pathogen that causes a self-limiting gastroenteritis. We describe the case of a 72-year-old woman admitted to our hospital because of acute abdominal colic pain. Over a 2-day period, her clinical condition deteriorated rapidly, with the appearance of acute abdomen. Computed tomography investigation of the abdomen showed a liver abscess (diameter approximately 3 cm). At laparotomy, the abscess was found to be ruptured to the free peritoneal cavity. The final clinical diagnosis was acute peritonitis due to a ruptured liver abscess. Bacillus cereus was isolated from culture of the pus. Up to now, no case of liver abscess due to this organism has been reported.
Asunto(s)
Abdomen Agudo/complicaciones , Bacillus cereus/crecimiento & desarrollo , Infecciones por Bacterias Grampositivas/complicaciones , Absceso Hepático/microbiología , Abdomen Agudo/microbiología , Abdomen Agudo/cirugía , Anciano , Resultado Fatal , Femenino , Infecciones por Bacterias Grampositivas/microbiología , Humanos , Laparotomía , Absceso Hepático/cirugíaRESUMEN
The woodchuck hepatitis virus (WHV)/woodchuck system is studied as animal model of human hepatocellular carcinoma (HCC) induced by chronic hepatitis B virus infection. The aim of the present study was the evaluation of ultrasound (US) liver examination in woodchuck as a routine method to detect HCC nodules and to follow their growth. Sixteen woodchucks were included in the study. US liver examination was carried out in all animals using a 5 MHz convex scanner. Macroscopic and microscopic examinations were performed to evaluate the US findings. The lower limit of nodule detection by US examination was a diameter of 5 mm. Macroscopic and microscopic examinations confirmed US findings in 14 of 16 animals (86.6%). No false negative results were obtained. Increase of nodule size was faster in the early phase of tumour growth. Small nodules (16 +/- 5 mm) appeared as hypoechoic lesions with well-defined margins and homogeneous structure. Large nodules (42 +/- 19 mm) appeared as hyperechoic lesions with irregular margins, heterogeneous or of mixed pattern; microscopical examination showed different degrees of necrosis, inflammation and fibrosis inside these latter neoplasms. The hepatitis reaction was conspicuously more severe around HCC nodules. No fibrosis and/or cirrhosis were found in normal liver parenchyma surrounding tumour nodules. On the whole, US appears to be helpful in the diagnosis of woodchuck HCC even at an early stage. Serial US evaluation can be used to study the growth rate of tumour nodules during natural history or experimental HCC treatments in woodchuck.
Asunto(s)
Carcinoma Hepatocelular/veterinaria , Virus de la Hepatitis B de la Marmota , Hepatitis B/veterinaria , Neoplasias Hepáticas/veterinaria , Marmota , Animales , Carcinoma Hepatocelular/diagnóstico por imagen , Carcinoma Hepatocelular/virología , Hepatitis B/diagnóstico por imagen , Hepatitis B/patología , Hígado/diagnóstico por imagen , Hígado/patología , Neoplasias Hepáticas/diagnóstico por imagen , Neoplasias Hepáticas/virología , UltrasonografíaRESUMEN
BACKGROUND: Hepatitis C virus (HCV) infection is common worldwide but there are different prevalence rates in different countries. Data on the incidence of HCV in the general population are scarce. Spontaneous viral clearance occurs in 10-25% of infected individuals after acute infection yet controversy exists regarding the frequency of spontaneous clearance during the natural course of HCV infection in the general population. AIMS: Anti-HCV prevalence, HCV infection rate, and the kinetics of anti-HCV were studied in a cross section of the general population of central Italy. STUDY POPULATION AND METHODS: Anti-HCV prevalence (EIA-3 Ortho, RIBA-3 Ortho Chiron) was estimated in 3884 randomly selected individuals. Infection rate and antibody kinetics were estimated in 2032 participants for whom a second blood sample was taken after a median follow up of seven years. HCV-RNA determination by polymerase chain reaction was performed on follow up sera. RESULTS: The overall confirmed anti-HCV prevalence was 2.4%. Two participants seroconverted for anti-HCV, giving an overall infection rate of 1.4 cases per 10 000 person years (95% confidence interval 0.2-5.2 per 10 000 person years). Of the 36 individuals confirmed as anti-HCV positive at enrollment, seven (19.4%) showed complete seroreversion. Seven (87%) of the eight individuals with indeterminate results at enrollment were serologically non-reactive at the end of follow up. Of the 25 participants confirmed to be anti-HCV positive at both enrollment and follow up, 23 (92.0%) with stable serological profiles tested positive for HCV-RNA at the end of follow up. CONCLUSIONS: There is still a permanent risk, although low, of HCV spread in the general population in an area of low level endemicity. In this setting, a wide spectrum of modifications of viral and antibody patterns can be observed in HCV infected patients.
Asunto(s)
Anticuerpos contra la Hepatitis C/sangre , Hepatitis C/epidemiología , Adulto , Distribución por Edad , Anciano , Estudios Transversales , Femenino , Estudios de Seguimiento , Hepacivirus/aislamiento & purificación , Hepatitis C/inmunología , Humanos , Italia/epidemiología , Modelos Logísticos , Masculino , Persona de Mediana Edad , ARN Viral/análisis , Estudios Retrospectivos , Estudios SeroepidemiológicosRESUMEN
BACKGROUND: The recently discovered TT virus (TTV) has been shown to be highly prevalent in patients with cryptogenetic chronic liver disease and fulminant hepatitis. To study the frequency of TTV and to evaluate the possible association with liver disease, 37 pediatric and young adult patients with thalassemia, and 36 healthy children were included in the study. The sera of 100 blood donors selected randomly in the same period were also tested for TTV DNA. METHODS: The TTV amplification by polymerase chain reaction (PCR) was performed using a first set of primers that recognize an internal sequence into N22 and a second set of primers amplifying a sequence within 5;NCR (5; noncoding region). RESULTS: The first set of primers revealed TTV DNA in 73% of thalassemic patients, in 8% of healthy children, and in 5% of healthy blood donors. With the second set of primers, the prevalence of TTV DNA was, respectively, 100% in thalassemic patients, 44.5% in healthy pediatric patients, and 87% in healthy blood donors. All individuals who tested positive for TTV by the first set of primers were also positive by the second primer set. The TTV infection seemed not to be the cause of altered transaminase levels. Sequencing of TTV clones from thalassemic patients showed the presence of different TTV variants in the same serum. CONCLUSION: The prevalence of TTV in polytransfused children is similar to that detected in blood donors. Moreover, TTV can be detected in healthy children of all ages. The presence of TTV seems to have no clinical significance.
Asunto(s)
Infecciones por Virus ADN/epidemiología , Talasemia/complicaciones , Torque teno virus/aislamiento & purificación , Adolescente , Adulto , Secuencia de Bases , Donantes de Sangre , Niño , Preescolar , Infecciones por Virus ADN/sangre , ADN Viral/análisis , ADN Viral/química , Femenino , Humanos , Lactante , Masculino , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Prevalencia , Análisis de Secuencia de ADN , Talasemia/sangre , Talasemia/virología , Torque teno virus/genética , Torque teno virus/patogenicidadRESUMEN
Susceptibility to 15 antibiotics was determined in 1548 non-typhoidal salmonella strains isolated in Greece from l990 to l997. The overall prevalence of resistance of both Salmonella enterica serotype Enteritidis and Salmonella enterica serotype Typhimurium increased during the first years of the study. A decrease was observed from 1996, especially for S. Enteritidis, which showed the highest overall antibiotic resistance. S. Typhimurium was the serotype with the highest multiresistance to antibiotics. The rest of the serotypes had very low resistance prevalence compared with both S. Enteritidis and Typhimurium serotypes.
Asunto(s)
Farmacorresistencia Bacteriana , Infecciones por Salmonella/tratamiento farmacológico , Salmonella enteritidis/efectos de los fármacos , Salmonella typhimurium/efectos de los fármacos , Grecia , Humanos , Pruebas de Sensibilidad Microbiana , Fenotipo , Infecciones por Salmonella/microbiología , Salmonella enteritidis/aislamiento & purificación , Salmonella typhimurium/aislamiento & purificaciónRESUMEN
BACKGROUND: The aim was to estimate the prevalence and the persistence of GB virus C/hepatitis G virus (GBV-C/HGV) exposure markers in a group at high risk for transfusion-transmitted agents. PATIENTS AND METHODS: Serum samples from 37 thalassemic patients were screened for GBV-C/HGV RNA by reverse transcription PCR (RT-PCR) and for antibodies to the envelope protein E2 of GBV-C/HGV (anti-E2). RESULTS AND DISCUSSION: GBV-C/HGV RNA and anti-E2 were detected in 13 (35%) and 12 (32%) sera, respectively. Contemporary presence of both markers was found in one patient. GBV-C/HGV exposure was found in 24 patients (64.8%). Mean levels of liver enzymes were similar in both exposed and unexposed GBV-C/HGV groups. 33 out of 35 patients showed no change in GBV-C/HGV RNA and anti-E2 status in sera taken 6 months apart. The rate of persistent infection was 92.3% and the anti-E2 seroconversion rate was 23% for sera taken at least 6 months apart. The temporal overlap between anti-E2 seroconversion and loss of detectable GBV-C/HGV RNA may last more than 6 months.
Asunto(s)
Infecciones por Flaviviridae/etiología , Virus GB-C/aislamiento & purificación , Hepatitis Viral Humana/etiología , Talasemia/terapia , Reacción a la Transfusión , Proteínas E2 de Adenovirus/inmunología , Adolescente , Adulto , Biomarcadores/sangre , Niño , Femenino , Infecciones por Flaviviridae/diagnóstico , Virus GB-C/genética , Virus GB-C/inmunología , Anticuerpos Antihepatitis/aislamiento & purificación , Hepatitis Viral Humana/diagnóstico , Humanos , Italia , Masculino , ARN Viral/aislamiento & purificación , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factores de RiesgoRESUMEN
Susceptibility to 15 antibiotics was determined in 1548 non-typhoidal salmonella strains isolated in Greece from l990 to l997. The overall prevalence of resistance of both Salmonella enterica serotype Enteritidis and Salmonella enterica serotype Typhimurium increased during the first years of the study. A decrease was observed from 1996, especially for S. Enteritidis, which showed the highest overall antibiotic resistance. S. Typhimurium was the serotype with the highest multiresistance to antibiotics. The rest of the serotypes had very low resistance prevalence compared with both S. Enteritidis and Typhimurium serotypes.
Asunto(s)
Farmacorresistencia Bacteriana , Salmonella/efectos de los fármacos , Animales , Farmacorresistencia Bacteriana Múltiple , Grecia , Humanos , Salmonella enteritidis/efectos de los fármacos , Salmonella typhimurium/efectos de los fármacos , Factores de TiempoRESUMEN
The susceptibility patterns of 1027 nontyphoidal Salmonella strains of human origin, isolated in Greece between 1990 and 1997, were determined by broth microdilution. From 1990 to 1995, the overall incindence of resistance for both Salmonella enteritidis and S. typhimurium increased. From 1996 onwards, a decrease was observed, which was more evident for S. enteritidis. Regarding the other examined serotypes a substantial proportion of resistant isolates was found only for S. Virhow and S.
Asunto(s)
Antibacterianos/farmacología , Salmonella/efectos de los fármacos , Distribución de Chi-Cuadrado , Farmacorresistencia Microbiana , Resistencia a Múltiples Medicamentos , Femenino , Grecia/epidemiología , Humanos , Incidencia , Masculino , Pruebas de Sensibilidad Microbiana , Salmonella/aislamiento & purificación , SerotipificaciónRESUMEN
BACKGROUND/AIM: The aim of the study was to estimate the prevalence, risk factors and genotype distribution of hepatitis C virus (HCV) in the general population older than 5 years of age in a southern Italian town. The positive predictive value of alanine transaminase (ALT) screening in identifying HCV positive subjects was also assessed. METHODS: Cluster random sampling from the census of the general population was used. ELISA and RIBA tests assessed the presence of anti-HCV; nested reverse transcription polymerase chain reaction (RT-PCR) was used to identify HCV-RNA; genotyping was performed by INNO-LIPA III. The association linking anti-HCV seropositivity with potential risk factors was assessed by multiple logistic regression analysis. RESULTS: Among the 488 subjects enrolled, 79 (16.2%) were anti-HCV positive. The prevalence increased from 1.2% in subjects 6-29 years of age to 42.1% in those > or = 60 years. Forty percent of these positive subjects also had abnormal ALT level and 54.4% were HCV RNA positive by PCR. The positive predictive value of the ALT test in identifying anti-HCV positive subjects was 65%; however, it was 46.7% in subjects younger than 60 years of age and 90.5% in those 60 or older. Genotype 1b was detected in 74% of subjects, type 2c in 23.3%, and type 1a in 2.3%. The only two variables significantly associated with HCV seropositivity in multivariate analysis were age older than 45 years (O.R. 8.5; CI 95%=3.0-24.1) and past use of glass syringes (O.R. 3.4; CI 95%=1.5-7.6). CONCLUSIONS: These findings confirm that HCV infection is endemic in southern Italy, particularly among the elderly. Percutaneous exposure, such as injections with nondisposable, multiple-use, glass syringes used in the past for medical purposes may have played a major role in the spread of HCV infection. ALT screening is not useful in detecting HCV positive subjects in the general population, particularly among subjects who could benefit from antiviral therapy.